Evidence map›Paper›PMID 36203452›Full record

ArticleFrontiers in oncology2022

Monitoring of telomere dynamics in peripheral blood leukocytes in relation to colorectal cancer patients' outcomes.

Kristyna Tomasova, Michal Kroupa, Alzbeta Zinkova, Marie Korabecna, Veronika Vymetalkova, Pavel Skrobanek, Ladislav Sojka, Miroslav Levy, Kari Hemminki, Vaclav Liska and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Telomere Length as a New Risk Marker of Early-Onset Colorectal Cancer.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Kristyna TomasovaDepartment of the Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czechia.
Michal KroupaDepartment of the Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czechia.
Alzbeta ZinkovaInstitute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czechia.
Marie KorabecnaInstitute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czechia.
Veronika VymetalkovaDepartment of the Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czechia.
Pavel SkrobanekDepartment of Oncology, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czechia.
Ladislav SojkaDepartment of Surgery, First Faculty of Medicine, Charles Univesity and Thomayer Hospital, Prague, Czechia.
Miroslav LevyDepartment of Surgery, First Faculty of Medicine, Charles Univesity and Thomayer Hospital, Prague, Czechia.
Kari HemminkiBiomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia.
Vaclav LiskaBiomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia.
Petr HosekBiomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia.
Rajiv KumarDepartment of the Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czechia.
Ludmila VodickovaDepartment of the Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czechia.
Pavel VodickaDepartment of the Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czechia.
Charles University · CZCzech Academy of Sciences, Institute of Experimental Medicine · CZThomayer University Hospital · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the possible associations between leukocyte telomere length, therapy outcomes, and clinicopathological features in patients with colorectal cancer. Additionally, telomerase reverse transcriptase (

Indexed as

adjuvant therapycolorectal cancerleukocyte telomere lengthlongitudinal monitoringTERT expression

Identifiers

PMID36203452
PMCPMC9530927
OpenAlexW4297907292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.